Drug intelligence / Profile preview

liuwei anshen

Development stage
Phase 4
Lead developer
Chongqing Pharscin Pharmaceutical
Administration
Oral
01

Overview

Liuwei Anshen is a Traditional Chinese Medicine (TCM) capsule formulation developed by the Oriental Hospital of Beijing University of Traditional Chinese Medicine. It is primarily indicated for the treatment of chronic insomnia, specifically targeting the "yin deficiency and fire hyperactivity with phlegm" syndrome. The therapeutic mechanism of Liuwei Anshen is currently being investigated through the lens of the inflammation-mediated microbial gut-brain axis, suggesting that the formula may exert its sedative and sleep-promoting effects by modulating gut microbiota composition and systemic inflammatory pathways. As a multi-component herbal preparation, it represents a holistic approach to managing sleep disorders within the framework of integrative medicine.

Brand names
Liuwei Anshen Capsule
Other names
Liuwei Anshen capsuleLiuwei Anshen formula
02

Targets

AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)BAX (Apoptosis regulator BAX)CASP3 (Caspase-3)IL-6 (Interleukin 6)MAPK14 (p38 mitogen-activated protein kinase alpha)MAPK3 (Mitogen-activated protein kinase 1)

Beyond the preview

Go deeper on liuwei anshen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on liuwei anshen.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call